Renaissance Technologies - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$1,248,000
+21.3%
269,000
+59.2%
0.00%
+50.0%
Q3 2015$1,029,000
+1154.9%
169,000
+823.3%
0.00%
Q1 2015$82,000
+60.8%
18,303
-31.4%
0.00%
Q3 2014$51,000
-87.9%
26,700
-78.6%
0.00%
-100.0%
Q2 2014$423,000
+29.8%
124,899
+28.2%
0.00%0.0%
Q1 2014$326,000
+59.0%
97,400
+46.0%
0.00%
Q4 2013$205,000
+6.2%
66,700
+38.8%
0.00%
Q3 2013$193,00048,0500.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 2,535,564$7,835,0004.00%
ProQuest Associates IV LLC 1,900,000$5,871,0002.39%
Abingworth LLP 437,994$1,349,0001.41%
Hilltop Park Associates LLC 75,000$232,0000.97%
Broadfin Capital, LLC 1,154,674$3,568,0000.35%
Perceptive Advisors 1,492,156$4,611,0000.32%
Rhenman & Partners Asset Management AB 300,000$927,0000.16%
Rock Springs Capital Management LP 450,000$1,391,0000.10%
WEXFORD CAPITAL LP 145,622$450,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 15,960$49,0000.02%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders